February 8, 2018 / 11:37 AM / 7 months ago

Regeneron posts 31 percent drop in quarterly profit

Feb 8 (Reuters) - Regeneron Pharmaceuticals Inc’s quarterly profit fell about 31 percent on Thursday, due to a charge of $381 million related to changes in U.S. tax laws.

Net income fell to $173.5 million, or $1.50 per share, in the quarter ended Dec. 31, from $253.1 million, or $2.19 per share, a year ago. (Reporting by Anuron Kumar Mitra and Tamara Mathias)

0 : 0
  • narrow-browser-and-phone
  • medium-browser-and-portrait-tablet
  • landscape-tablet
  • medium-wide-browser
  • wide-browser-and-larger
  • medium-browser-and-landscape-tablet
  • medium-wide-browser-and-larger
  • above-phone
  • portrait-tablet-and-above
  • above-portrait-tablet
  • landscape-tablet-and-above
  • landscape-tablet-and-medium-wide-browser
  • portrait-tablet-and-below
  • landscape-tablet-and-below